To overcome such inherent challenges, scientists are turning to more robust molecular solutions that improve cancer cell targeting and therapeutic outcomes, among the most promising of which are ...
A new approach targets the B-cell pathway with bispecific antibodies, building on decades of research that establishes the role of B cells and self-reactive antibodies in lupus, systemic sclerosis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results